Transfusion-associated bacterial sepsis is a persistent problem in transfus
ion medicine, posing a greater threat than the combined risks of receiving
a blood product contaminated with HIV-1 or 2, hepatitis C virus (HCV), hepa
titis B virus (HBV), and human T-cell lymphtrophic virus (HTVL) -I or -II.
This article provides a brief overview of the current incidence, clinical p
resentation, associated blood products and organisms, and the most feasible
and effective methods available to reduce the potential risk of transfusio
n-associated sepsis. Because bacterial contamination of blood products is t
he most frequent cause of transfusion-transmitted infectious disease, and a
s no single existing strategy can completely eliminate its risk, it is impo
rtant that clinical suspicion be high, and any partial solutions additively
be implemented. (C) 2001 Lippincott Williams & Wilkins, Inc.